Ifenprodil
CARDIOVASCULAR SYSTEM
Also known as: ifenprodil tartrate
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Ifenprodil is a drug catalogued in DrugCentral. DrugCentral lists 19 molecular targets, including Tspo, SIGMAR1 and Sigmar1.
- Molecular targets: Tspo, SIGMAR1, Sigmar1 and EBP (19 listed in DrugCentral).
- ATC code: C04AX28 (Other peripheral vasodilators).
- Molecular formula: C21H27NO2; molecular weight 325.45 g/mol.
Mechanism & targets
Molecular targets (19)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Translocator protein | Tspo | unknown | IC50 9.14 |
| Sigma non-opioid intracellular receptor 1 | SIGMAR1 | unknown | Ki 8.99 |
| Sigma non-opioid intracellular receptor 1 | Sigmar1 | unknown | Ki 8.70 |
| 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase | EBP | unknown | Ki 8.57 |
| Sigma non-opioid intracellular receptor 1 | SIGMAR1 | unknown | IC50 8.41 |
| Glutamate NMDA receptor; GRIN1/GRIN2B | GRIN1|GRIN2B | unknown | Ki 8.00 |
| Glutamate [NMDA] receptor subunit epsilon 2 | Grin2b | unknown | Ki 7.96 |
| Glutamate receptor ionotropic, NMDA 2B | GRIN2B | unknown | IC50 7.70 |
| Glutamate receptor ionotropic, NMDA 1 | Grin1 | unknown | IC50 7.14 |
| Sigma intracellular receptor 2 | Tmem97 | unknown | Ki 7.01 |
| Potassium voltage-gated channel subfamily H member 2 | KCNH2 | unknown | IC50 7.00 |
| Adrenergic receptor alpha-1 | Adra1b|Adra1d|Adra1a | unknown | IC50 7.00 |
| Alpha-2A adrenergic receptor | Adra2a | unknown | IC50 6.96 |
| 5-hydroxytryptamine receptor 1A | Htr1a | unknown | IC50 6.62 |
| 5-hydroxytryptamine receptor 2A | HTR2A | unknown | IC50 6.21 |
| Histamine H1 receptor | HRH1 | unknown | IC50 6.00 |
| Glutamate receptor ionotropic, NMDA 2C | GRIN2C | unknown | IC50 4.54 |
| Glutamate receptor ionotropic, NMDA 2A | GRIN2A | unknown | IC50 4.40 |
| Glutamate receptor ionotropic, NMDA 2D | GRIN2D | unknown | IC50 4.12 |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
C04AX28 | CARDIOVASCULAR SYSTEM › PERIPHERAL VASODILATORS › PERIPHERAL VASODILATORS › Other peripheral vasodilators |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Inappropriate antidiuretic hormone secretion | 63.2 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Ifenprodil is on its molecule page.
| Molecular formula | C21H27NO2 |
|---|---|
| Molecular weight | 325.45 g/mol |
| CAS number | 23210-56-2 |
| InChIKey | UYNVMODNBIQBMV-UHFFFAOYSA-N |
| PubChem CID | 3689 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Ifenprodil work?
Its molecular targets in DrugCentral include Tspo, SIGMAR1, Sigmar1 and EBP.
What is the chemical formula of Ifenprodil?
Ifenprodil has the molecular formula C21H27NO2 and a molecular weight of 325.45 g/mol.
Browse: all drugs starting with I · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1419 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1886888 — compound record and bioactivity
- PubChem CID 3689 — chemical identifiers
- DrugBank DB08954 — drug record
- FDA UNII R8OE3P6O5S — substance identity
- UniProt Q99720 (SIGMAR1) — target protein
- UniProt Q13224 (GRIN2B) — target protein
- UniProt Q12809 (KCNH2) — target protein
- UniProt P35367 (HRH1) — target protein
- UniProt Q14957 (GRIN2C) — target protein
- UniProt Q12879 (GRIN2A) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.